Maddy summaryThis bill empowers the Health Policy Commission to investigate whether nonprofit hospitals are setting drug prices that are unreasonable or excessive. Upon receiving a referral, the commission can require hospitals to submit detailed information about their pricing methods, including how they calculate markups and how they treat drugs acquired under the 340B program. While the bill mandates the disclosure of specific pricing data, it includes strong confidentiality protections to prevent hospitals from revealing trade secrets or sensitive financial details. If the commission finds a price is too high, it will issue a public report with findings and recommendations, which may then trigger an independent investigation by the Attorney General. Ultimately, the legislation aims to increase transparency in hospital drug pricing without directly mandating specific price reductions.
Sen. Mike Rush
Sponsored bills
Maddy summaryThis bill (S 2121) appears to be a procedural amendment to a larger appropriations bill (relating to fiscal year 2018 funding), not a standalone policy bill about community benefit districts. The provided abstract only identifies it as "Senate, May 24, 2017 -- Text of amendment (596) ... to the Ways and Means amendment" within the context of state budget appropriations. No specific policy provisions, mechanisms, or direct effects on communities or districts are described in the abstract. Without details on what the amendment actually changes regarding community benefit districts, a substantive summary cannot be provided. This appears to be a technical amendment to funding allocations, not a bill creating or altering community benefit district structures.
Maddy summaryThis amendment incorporates recommendations from the Foundation Budget Review Commission into the state's fiscal year 2018 appropriations bill. It directs the budget process to consider these recommendations when allocating funds to state agencies and programs. The bill does not create new laws but adjusts how budget decisions are made for the 2018 fiscal year.